Valeant Pharmaceuticals To Participate At Healthcare Conferences

February 13, 2017

LAVAL, Quebec, Feb. 13, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences:

  • 2017 RBC Capital Markets' Healthcare Conference on Thursday, February 23, 2017 at 9:00 a.m. ET at the New York Palace Hotel; and,

  • Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 8:30 a.m. ET at the Loews Miami Beach Hotel.

A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant and forward looking statements can be found at www.valeant.com.

Contact Information:

Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)

Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-at-healthcare-conferences-300405732.html

SOURCE Valeant Pharmaceuticals International, Inc.

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All